OPT: Multiplikator Forward P/S Opthea Corp

Logo korporat perusahaan Opthea Corp (OPT)

Opthea Limited (OPT) collaborates with ophthalmology centers to test methods for combating macular degeneration. The projected P/S multiple demonstrates valuation dynamics, with the indicator holding at 5776.30. High-quality Australian management ensures the transparency of trials. FDA approval of the unique drug will allow Opthea Limited (OPT) to exercise pricing power over the therapy, complementing existing market blockbusters.

opthea.com - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep OPT (periode 04.07.2022 - 28.06.2025)

Rincian metrik komprehensif lan analitis Opthea Corp (OPT)

- rega saham lan target rega konsensus:
Kutipan saham Opthea|OPT - Rega prakiraan analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar Opthea Corp|OPT - Nilai Dipunlarasaken Utang lan Kas
- statistik nilai buku emiten:
Nilai Buku saben Saham Opthea|OPT - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku opthea.com|OPT - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Opthea Limited|OPT - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Opthea Limited|OPT - Utang perusahaan|Utang-utang marang kapitalisasi buku Opthea Corp|OPT - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Opthea|Rasio cepet opthea.com
- rincian asil keuangan lan kelipatan valuasi:
OPT - Asil keuangan resik|Bathi mangsa ngarep Opthea Limited|OPT - Rasio rega pasar marang bathi resik|Pangali Forward P/E Opthea Ltd.|OPT - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Opthea Corp|OPT - Bathi operasional sadurunge amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Opthea|OPT - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan opthea.com|OPT - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Opthea Limited
- rincian pendapatan lan dodolan:
OPT - Total dodolan perusahaan|Prakiraan pendapatan perusahaan Opthea|OPT - Rasio rega marang dodolan|Multiplikator Forward P/S Opthea Corp
Ringkesan analitik perusahaan:Opthea OPT
Produk sing diprodhuksi Opthea Limited

For Opthea Limited, which focuses on developing treatments for macular degeneration, an analysis of forward EV/Revenue allows for an assessment of market expectations regarding future investment inflows. This indicator compares the company's current valuation with projected revenues, neutralizing short-term market noise and currency volatility to determine the fundamental trend of the long-term consensus business value.

Analisis perusahaan pesaing

Alcon - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake BLCO (Bausch & Lomb)|Glaukos Corp. - Multiplikator Forward P/S|Rega forward marang dodolan APLS (Apellis Corp)|BLTE: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ocutx.com (OCUL)|HROW (Harrow) - Multiplikator Forward P/S|Multiplikator Forward P/S Viridian Therapeutics Inc|Multiplikator forward rega marang pendapatan LENZ (LENZ Pharma)|OCS (Oculis Pharma) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan EyePoint Pharmaceuticals EYPT|kodiak.com - Rasio rega marang prakiraan pendapatan|Aldeyra - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake KALA BIO, Inc. KALA|opusgtx.com (IRD) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan OKYO Pharma|ADVM (Adverum Biotechnologies Inc.) - Multiplikator Forward P/S|outlooktherapeutics.com (OTLK) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan CLSD (Clearside Biomedical, Inc.)|Rasio rega marang pendapatan sing dikarepake NBY|Multiplikator Forward P/S KPRX (Kiora Pharmaceuticals, Inc.)|Alimera Sciences Inc (ALIM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Eyenovia Corp - Multiplikator Forward P/S|GHSI (guardionhealth.com) - Kapitalisasi marang prakiraan pendapatan|Ocuphire Pharma (OCUP) - Rasio rega marang prakiraan pendapatan